IBDEI0S5 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12553,0)
 ;;=L98.3^^80^782^82
 ;;^UTILITY(U,$J,358.3,12553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12553,1,3,0)
 ;;=3^Eosinophilic Cellulitis,Skin/Subcutaneous
 ;;^UTILITY(U,$J,358.3,12553,1,4,0)
 ;;=4^L98.3
 ;;^UTILITY(U,$J,358.3,12553,2)
 ;;=^5009576
 ;;^UTILITY(U,$J,358.3,12554,0)
 ;;=L72.0^^80^782^83
 ;;^UTILITY(U,$J,358.3,12554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12554,1,3,0)
 ;;=3^Epidermal Cyst
 ;;^UTILITY(U,$J,358.3,12554,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,12554,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,12555,0)
 ;;=L72.9^^80^782^84
 ;;^UTILITY(U,$J,358.3,12555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12555,1,3,0)
 ;;=3^Follicular Cyst of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,12555,1,4,0)
 ;;=4^L72.9
 ;;^UTILITY(U,$J,358.3,12555,2)
 ;;=^5009283
 ;;^UTILITY(U,$J,358.3,12556,0)
 ;;=L60.0^^80^782^86
 ;;^UTILITY(U,$J,358.3,12556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12556,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,12556,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,12556,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,12557,0)
 ;;=C43.9^^80^782^87
 ;;^UTILITY(U,$J,358.3,12557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12557,1,3,0)
 ;;=3^Malig Melanoma of Skin,Unspec
 ;;^UTILITY(U,$J,358.3,12557,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,12557,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,12558,0)
 ;;=D03.9^^80^782^91
 ;;^UTILITY(U,$J,358.3,12558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12558,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,12558,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,12558,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,12559,0)
 ;;=L72.8^^80^782^85
 ;;^UTILITY(U,$J,358.3,12559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12559,1,3,0)
 ;;=3^Follicular Cyst of Skin/Subcutaneous Tissue NEC
 ;;^UTILITY(U,$J,358.3,12559,1,4,0)
 ;;=4^L72.8
 ;;^UTILITY(U,$J,358.3,12559,2)
 ;;=^5009282
 ;;^UTILITY(U,$J,358.3,12560,0)
 ;;=L72.2^^80^782^93
 ;;^UTILITY(U,$J,358.3,12560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12560,1,3,0)
 ;;=3^Steatocystoma Multiplex
 ;;^UTILITY(U,$J,358.3,12560,1,4,0)
 ;;=4^L72.2
 ;;^UTILITY(U,$J,358.3,12560,2)
 ;;=^5009280
 ;;^UTILITY(U,$J,358.3,12561,0)
 ;;=L72.12^^80^782^94
 ;;^UTILITY(U,$J,358.3,12561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12561,1,3,0)
 ;;=3^Trichodermal Cyst
 ;;^UTILITY(U,$J,358.3,12561,1,4,0)
 ;;=4^L72.12
 ;;^UTILITY(U,$J,358.3,12561,2)
 ;;=^5009279
 ;;^UTILITY(U,$J,358.3,12562,0)
 ;;=E11.621^^80^782^81
 ;;^UTILITY(U,$J,358.3,12562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12562,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,12562,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,12562,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,12563,0)
 ;;=C44.309^^80^782^88
 ;;^UTILITY(U,$J,358.3,12563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12563,1,3,0)
 ;;=3^Malig Neop of Skin of Face,Other Parts
 ;;^UTILITY(U,$J,358.3,12563,1,4,0)
 ;;=4^C44.309
 ;;^UTILITY(U,$J,358.3,12563,2)
 ;;=^5001042
 ;;^UTILITY(U,$J,358.3,12564,0)
 ;;=C44.300^^80^782^89
 ;;^UTILITY(U,$J,358.3,12564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12564,1,3,0)
 ;;=3^Malig Neop of Skin of Face,Unspec Part
 ;;^UTILITY(U,$J,358.3,12564,1,4,0)
 ;;=4^C44.300
 ;;^UTILITY(U,$J,358.3,12564,2)
 ;;=^5001040
 ;;^UTILITY(U,$J,358.3,12565,0)
 ;;=C44.301^^80^782^90
 ;;^UTILITY(U,$J,358.3,12565,1,0)
 ;;=^358.31IA^4^2
